Cell Signaling Technology

Itk (2F12) Mouse Monoclonal Antibody

#2380 · western blot · $180,416

64

Evidence Score · Well-Established

Used by 265 independent labs across 354 papers. How we score this →

100

Citing papers

23.7k

Combined citations

Supplier page Find this product

Research areas

Sirtuins and Resveratrol in Medicine19 Autophagy in Disease and Therapy11 Lung Cancer Treatments and Mutations10 MicroRNA in disease regulation9 NF-κB Signaling Pathways8 Immune Response and Inflammation8 Cancer-related molecular mechanisms research6 Genomics, phytochemicals, and oxidative stress5

Papers citing this product

1

TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

Journal of Clinical Investigation·2000·1.4k cit.·DOI

2

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Nature Microbiology·2020·1.4k cit.·DOI

3

EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition

Institutional Repositories DataBase (IRDB)·2014·741 cit.

4

Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus

Journal of Biological Chemistry·2004·672 cit.·DOI

5

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

Nature Communications·2016·657 cit.·DOI

6

Chronic Sleep Disruption Alters Gut Microbiota, Induces Systemic and Adipose Tissue Inflammation and Insulin Resistance in Mice

Scientific Reports·2016·466 cit.·DOI

7

Motif module map reveals enforcement of aging by continual NF-κB activity

Genes & Development·2007·454 cit.·DOI

8

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor <i>BRAF</i> gene mutations but lack mutations in <i>KRAS, NRAS,</i> or <i>MEK1</i>

Proceedings of the National Academy of Sciences·2012·436 cit.·DOI

9

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

Nature Communications·2017·409 cit.·DOI

10

TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Proceedings of the National Academy of Sciences·2010·385 cit.·DOI

Similar products

Product	Vendor	Evidence	Price	Papers
Itk (2F12) Mouse Monoclonal Antibody (Biotinylated)Mouse	Cell Signaling Technology	64	$556	200
ITK (E4X7M) Rabbit Monoclonal Antibody (BSA and Azide Free)Rabbit	Cell Signaling Technology	64	$865	46
ITK (E4X7M) Rabbit Monoclonal Antibody (Biotinylated)Rabbit	Cell Signaling Technology	64	$556	5
ITK (E4X7M) Rabbit Monoclonal AntibodyRabbit	Cell Signaling Technology	64	$176,409	2

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.